Illumina

Senior Territory Account Manager

Qingdao, China

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Genomics, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree and have at least 5 years of experience in sales, with a strong understanding of the genetic analysis market, particularly within the Shandong/Tianjin/Heibei/Shanxi region. Proven ability to develop and maintain high-value customer accounts, utilize CRM databases, and provide accurate sales forecasts are essential. Strong negotiation skills and the ability to establish professional relationships with internal and external stakeholders are also required.

Responsibilities

The Senior Territory Account Manager will represent the company professionally, ethically, and morally, ensuring achievement of territory sales objectives through strategic and tactical activities. They will develop high-value customer accounts by selling Illumina’s products and services, participate in sales activities, provide customer demonstrations and training, coordinate sales activities, develop and maintain account details in the CRM database, provide regular sales forecasts, assist with territory planning, maintain relationships with internal customers and product development groups, establish a comprehensive database of users, identify trends in usage, spend a significant amount of time in the field developing customer relationships, negotiate genetic analysis sales, assist with recruitment, and aid in the development of new sales territories.

Skills

Sales
Customer Relationship Management (CRM)
Account Management
Strategic Planning
Market Analysis
Communication
Training and Support

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI